Skip to main content
Log in

Short-term treatment of gastric ulcer

A meta-analytical evaluation of blind trials

  • Esophageal, Gastric, And Duodenal Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Gastric ulcer is relatively infrequent, and clinical trials are often based on small-sized samples. The aim of this study was to define the “gold standard” therapy of active gastric ulcer. We included all single- or double-blind clinical trials on the short-term treatment of gastric ulcer. All the articles published over the period 1977–1994 were reviewed. Meta-analysis was done with both fixed and random effect models; results were shown using Galbraith's radial plot. Forty-eight papers comprising 52 studies were evaluated. Cimetidine, ranitidine, and famotidine proved significantly better than placebo [odds ratio (OR) and 95% confidence interval (CI 95%) at four to six weeks were: 2.67 (2.03–3.52), 3.94 (2.28–6.80), 1.76 (1.08–2.88), respectively]. Cimetidine and ranitidine had results comparable with the newer H2 blockers [OR (CI 95%) at four weeks: 1.16 (0.91–1.47), 1.11 (0.80–1.55), respectively]. H2 blockers were proved comparable with either sucralfate [OR (CI 95%) at eight weeks: 0.81 (0.37–1.79)] or bismuth [OR (CI 95%) at four to six weeks: 0.67 (0.37–1.20)]. Omeprazole is more effective than H2 blockers [OR (CI 95%) at four weeks: 2.00 (1.57–2.55)]. It is concluded that H2 blockers are preferred to either a placebo or sucralfate for short-term gastric ulcer treatment; the newer H2 blockers do not have significant advantages over the older types; omeprazole can be regarded as the “gold standard” for active gastric ulcer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pulvertaft CN: Comments on the incidence and natural history of gastric and duodenal ulcer. Postgrad Med J 44:597–602, 1968

    Google Scholar 

  2. Kurata JH, Honda GD, Frankl H: The incidence of gastric and duodenal ulcers in a large HMO (health maintenance organization). 11th Annual Meeting of the American Public Health Association 1983 (abstract)

  3. Sipponen P: Chronic gastritis and ulcer risk. Scand J Gastroenterol 25:193–196, 1990

    Google Scholar 

  4. Vaira D, Miglioli M, Mulè P, Menegatti M, Vergura M, Barbara L: Gastric ulcer andHelicobacter pylori.In: Gastric Ulcer. G Battaglia, F Di Mario, F Vianello (eds). Padua, Piccin Nuova Libraria, 1995; pp 49–54

    Google Scholar 

  5. Tatsuta M, Ishikawa H, Iishi H, Okuda S, Yokota Y: Reduction of gastric ulcer recurrence after suppression ofHelicobacter pylori by cefixime. Gut 31:973–976, 1990

    Google Scholar 

  6. Labenz J, Börsch G: Evidence for the essential role ofHelicobacter pylori in gastric ulcer disease. Gut 35:19–22, 1994

    Google Scholar 

  7. Galbraith RF: A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7:889–894, 1988

    Google Scholar 

  8. L'Abbé KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med 107:224–233, 1987

    Google Scholar 

  9. Robins J, Breslow N, Greenland S: Estimators of the Mantel-Henszel variance consistent in both sparse data and large strata limiting models. Biometrics 42:311–323, 1986

    Google Scholar 

  10. Simes RJ: Confronting publication bias: A cohort design for meta-analysis. Stat Med 6:11–29, 1987

    Google Scholar 

  11. Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, McIlroy W, Oxman AD: Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 269:2749–2753, 1993

    Google Scholar 

  12. Rosenthal R: The “file-drawer problem” and tolerance for null results. Psychol Bull 86:638–641, 1979

    Google Scholar 

  13. Klein S, Simes J, Blackburn GL: Total parenteral nutrition and cancer clinical trials. Cancer 58:1378–1386, 1986

    Google Scholar 

  14. Bader JP, Morin T, Bernier JJ, et al: Treatment of gastric ulcer by cimetidine. A multicentre trial.In: Cimetidine. Burlaud WL, Simkins MA (eds). Amsterdam-Oxford, Excerpta Medica, 1977, pp 287–292

    Google Scholar 

  15. Frost F, Rahbek I, Rune SJ, Birger Jensen K, Gudmand-Hoyer E, Krag E, Rask-Madsen J, Wulff HR, Garbol J, Gotlieb Jensen K, Hojlund M, Nissen VR: Cimetidine in patients with gastric ulcer: A multicentre controlled trial. Br Med J 2:795–799, 1977

    Google Scholar 

  16. Englert E, Freston JW, Graham DY, Finkelsfein W, Kruss DM, Priest RJ, Raskin JB, Rhobes JB, Rogers AZ, Wenger J, Wilcox LL, Crossley J: Cimetidine, antacid and hospitalization in the treatment of benign gastric ulcer. Gastroenterology 74:416–425, 1978

    Google Scholar 

  17. Cremer M, Toussaint J, Derumier J, Delterne M: Etude en double avengle de l'effet de le cimetidine dans l'ulcere duodenal et dans l'ulcere gastrique.In: National Symposium on Cimetidine. Harvengt C (ed). Brussels, Excerpta Medica, 1978, pp 30–39

    Google Scholar 

  18. Lambert R: Traitment de l'ulcere gastrique par le cimetidine resultats de l'étude multicentrique francaise.In: National Symposium on Cimetidine. Harvengt C (ed) Brussels, Excerpta Medica, 1978, pp 46–50

    Google Scholar 

  19. Dick WP, Belsito A, Fleshler B, Liebermann TR, Dickinson PB, Wood JM: Cimetidine and placebo in the treatment of benign gastric ulcer. Gastroenterology 74:410–415, 1978

    Google Scholar 

  20. Navert H, Tetreault T, Wollin A, Beaudry R, Haddad H: An evaluation of the therapeutic efficacy of cimetidine in gastric ulcer. Criteria for methods of analysis.In: Abstracts, VI Asian Pacific Congress of Gastroenterology. Auckland, New Zealand, 1980

  21. Ciclitira PH, Machell RJ, Farthing MJG, Dick AP, Hunter JO: Double-blind controlled trial of cimetidine in the healing of gastric ulcer. Gut 20:730–734, 1977

    Google Scholar 

  22. Landecker KD, Crawford J, Hunt JH, Gillespie CP, Piper DW: Cimetidine and gastric ulcer healing. A double-blind controlled trial. Med J Aust 2:43–45, 1979

    Google Scholar 

  23. Clarke AC, Lee SP, Tasman-Jones C: Effects of cimetidine on the healing of benign gastric ulcers. Aust NZ J Med 10(4):430–432, 1980

    Google Scholar 

  24. Isenberg JI, Peterson WL, Elashoff JD, Sandersfeld MA, Reedy TJ, Ippoliti AF, Van Deventer GM, Frankl H, Longstreth GF, Anderson DS: Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind randomized, placebo-controlled trial. N Engl J Med 308:1319–1324, 1983

    Google Scholar 

  25. Dawson J, Jain S, Cockel R: Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence. Scand J Gastroenterol 19:665–668, 1984

    Google Scholar 

  26. Graham DY, Akdamar K, Dyck W, Englert E, Strickland RG, Achord JL, Belsito AA, Reno Vlahcevic Z, Kornfield RN, Long WB, Sontag S, Agrawal NM: Healing of benign gastric ulcer: Comparison of cimetidine and placebo in the United States. Ann Intern Med 102:573–576, 1985

    Google Scholar 

  27. Frank WO, Young M, Palmer RH, Karlstadt R, Rockhold F, Mounce W: Once-daily bedtime dosing regimen of cimetidine in the treatment of gastric ulcers. Clin Ther 11(5):595–603, 1989

    Google Scholar 

  28. Ryan FP: A comparison of ranitidine and placebo in the acute treatment of gastric ulcer.In: The Clinical Use of Ranitidine. The Medicine Publishing Foundation, Oxford, UK, 1982, pp 201–205

    Google Scholar 

  29. Schultz TB, Berstad A, Rydning A, Frislid K: Treatment of gastric ulcer with ranitidine. Scand J Gastroenterol 19:119–121, 1984

    Google Scholar 

  30. Darle N, Almskog B, Falk A, Fredriksen B, Gamklou R, Ivarsson L, Karlström L: Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer. A controlled prospective double-blind trial. Ann Clin Res 16:6–9, 1984

    Google Scholar 

  31. Hirschowitz BI, De Luca V, Graham D, Lorber S, Bright-Asare P, Katon R: Treatment of benign chronic gastric ulcer with ranitidine. A randomized, double-blind, and placebo-controlled six week trial. J Clin Gastroenterol 8(3):371–376, 1986

    Google Scholar 

  32. Johnson JA, Euler AR, Northcutt AR, McSorley DJ: Ranitidine 300 mg at bedtime is effective for gastric ulcers: a 12-wk, multicenter, randomized, double-blind, placebo-controlled comparison. The Ranitidine 300 mg HS Gastric Ulcer Study Group. Am J Gastroenterol 88(7):1071–1075, 1993

    Google Scholar 

  33. Paoluzi P, Torsoli A, Bianchi-Porro G, Lazzaroni M, Barbara L, Corinaldesi R, Blasi A, Mangiameli A, Carratelli L, Cheli R, Bovero E, Dal Monte PR, D'Imperio N, Francavilla A, Doronzo F, Mazzacca G, Sabbatini F, Verme G, Ponti V, Speranza V, Le Zoche E, Baglioni A, Carotenuto F, Matarazzo PF: Famotidine (MK-208) in the treatment of gastric ulcer. Digestion 32(S1):38–44, 1985

    Google Scholar 

  34. Dammann HG, Walter TA, Hentschel E, Muller P, Simon B: Famotidine: Nocturnal administration for gastric ulcer healing. Results of multicentre trials in Austria and Germany. Digestion 32(S1):45–50, 1985

    Google Scholar 

  35. Bianchi-Porro G: Famotidine in the treatment of gastric and duodenal ulceration: Overview of clinical experience. Digestion 32(S1):62–69, 1985

    Google Scholar 

  36. Wright JP, Marks IN, Mee AS, Girdwood AD, Bornman PC, Gilinsky NH, Tobias R, Lucke W: Ranitidine in the treatment of gastric ulcers disease.In: The Clinical Use of Ranitidine. The Medicine Publishing Foundation Oxford, UK, 1982, pp 214–221

    Google Scholar 

  37. Baron JH, Perrin VL, et al: Gastric ulcer healing with ranitidine and cimetidine. A multicentre study. Scand J Gastroenterol 18:973–976, 1983

    Google Scholar 

  38. Kellow JE, Barr GD, Cowen AE, Ward M, Wood L, Piper DW: Comparison of ranitidine and cimetidine in the treatment of chronic gastric ulcer. A double-blind trial. Digestion 27:105–110, 1983

    Google Scholar 

  39. The Belgian Peptic Ulcer Study Group: Single-blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. Gut 25:999–1002, 1984

    Google Scholar 

  40. Inoue M: Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan. Drugs 35(S3):114–119, 1988

    Google Scholar 

  41. Perez-Mota A, Garcia-Plaza A, Rodrigo M, Castro L, Casanova A, Cano A, Garcia-Hoz F, Perez E, Ruiz-Capellan R: Famotidine versus cimetidine in the treatment of benign gastric ulcers. A multicentre, double-blind study. Curr Ther Res 47:814–819, 1990

    Google Scholar 

  42. Naccarato R, Cremer M, Dammann HG, Keohane PP, Mulder H, Sarles H, Simon B, Members of the European Nizatidine Gastric Ulcer Study Group: Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial. Scand J Gastroenterol 22(S136):71–78, 1987

    Google Scholar 

  43. Judmaier G: A comparison of roxatidine acetate and ranitidine in gastric ulcer healing. Drugs 35(S3):120–126, 1988

    Google Scholar 

  44. Brazer SR, Tyor MP, Pancotto FS, Brice RS, Garbutt JT, Wildermann NM, Harrel FE, Pryor DB, The Study Group: Randomized, double-blind, comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Community-based study coupled with a patient registry. Dig Dis Sci 34(7):1047–1052, 1989

    Google Scholar 

  45. Lahtinen J, Aukee S, Miettinen P, Poikolainen E, Paakkonen M, Sandstrom R: Sucralfate and cimetidine for gastric ulcer. Scand J Gastroenterol 18(S83):49–51, 1983

    Google Scholar 

  46. Martin F, Farley A, Gagnon M, Poitras P, Bensemana D: Short-term treatment with sucralfate or cimetidine in gastric ulcers: preliminary results of a controlled randomized trial. Scand J Gastroenterol 18(S83):37–41, 1983

    Google Scholar 

  47. Pop P, Nikkels RE, Thys O, Dorrestein GCM: Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicentre study. Scand J Gastroenterol 18(S83):43–47, 1983

    Google Scholar 

  48. Hallerbäck B, Anker-Hansen O, Carling L, Glise H, Solhaug JH, Svedberg LE, Wahlby L: Short term treatment of gastric ulcer: A comparison of sucralfate and cimetidine. Gut 27:778–783, 1986

    Google Scholar 

  49. Hjortrup A, Svendsen LB, Beck H, Hoffmann J, Schroeder M: Two daily doses of sucralfate or cimetidine in the healing of gastric ulcer. A comparative randomized study. Am J Med 86(S6A):113–115, 1989

    Google Scholar 

  50. Blum AL, Bethge H, Bode JC, Domschke W, Feurle G, Hackenberg K, Hammer B, Huttemann W, Jung M, Kachel G: Sucralfate in the treatment and prevention of gastric ulcer: Multicentric double-blind placebo controlled study. Gut 31(7):825–830, 1990

    Google Scholar 

  51. Tanner AR, Cowlishaw JL, Cowen AE, Ward M: Efficacy of cimetidine and tri-potassium di-citrato bismuthate (De-Nol) in chronic gastric ulceration: A comparative study. Med J Austr 1:1–2, 1979

    Google Scholar 

  52. Tytgat GNJ, Rauws E, Langenberg W: The role of colloidal bismuth subcitrate in gastric ulcer and gastritis. Scand J Gastroenterol 17(S80):31–38, 1982

    Google Scholar 

  53. Parente F, Lazzaroni M, Petrillo M, Bianchi-Porro G: Colloidal bismuth subcitrate and ranitidine in the short-term treatment of benign gastric ulcer. An endoscopically controlled trial. Scand J Gastroenterol 21(S122):42–45, 1986

    Google Scholar 

  54. Classen M, Dammann HG, Domschke W, Huttemann W, Londong W, Rehner M, Scholten T, Simon B, Witzel L, Berger J: Abheilungsraten nach Omeprazol-und Ranitidin-Behandlung des Ulcus ventriculi. Dtsch Med Wochenschr 110:628–633, 1985

    Google Scholar 

  55. Bate CM, Wilkinson SP, Bradby GVH, Bateson MC, Hislop WS, Crowe JP, Willoughby CP, Peers EM, Richardson PDI: Randomized, double-blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut 30:1323–1328, 1989

    Google Scholar 

  56. Danish Omeprazole Study Group: Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: A double-blind comparative trial. Br Med J 298:645–647, 1989

    Google Scholar 

  57. Walan A, Bader JP, Classen M, Lamers C, Piper DW, Rutgersson K, Eriksson S: The effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 320:69–75, 1989

    Google Scholar 

  58. Cooperative Study Group: Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Gut 31:653–656, 1990

    Google Scholar 

  59. Choi KW, Sun HS, Yoon CM, Park KN, Min YI, Chang R, Lee SI, Chung JM, Yang US, Wong EC: A double-blind, randomized, parallel group study of omeprazole and ranitidine in Korean patients with gastric ulcer. J Gastroenterol Hepatol 9(2):118–123, 1994

    Google Scholar 

  60. Singh P, Colin-Jones DG: Modern management of peptic ulceration. Br J Hosp Med 47(1):44–50, 1992

    Google Scholar 

  61. Feldman M, Burton ME: Histamine2-receptor antagonists—standard therapy for acid-peptic diseases (second of two parts). N Engl J Med 323:1749–1755, 1990

    Google Scholar 

  62. Jimenez E, Bosch F, Galmes JL, Banos JE: Meta-analysis of efficacy of zinc acexamate in peptic ulcer. Digestion 51(1):18–26, 1992

    Google Scholar 

  63. Blum AL: Treatment of acid-related disorders with gastric acid inhibitors: the state of the art. Digestion 47(suppl 1):3–10, 1990

    Google Scholar 

  64. Bardhan KD, Ahlberg J, Hislop WS, Lindholmer C, Long RG, Morgan AG, Sjostedt S, Smith PM, Stig R: Rapid healing of gastric ulcers with lansoprazole. Aliment Pharmacol Ther 8(2):215–220, 1994

    Google Scholar 

  65. Michel P, Lemaire M, Colin R, Bommelaer G, Rambaud JC, Dupas JL, Bigard MA, Verwaerd JC: Short report: Treatment of gastric ulcer with lansoprazole or ranitidine: A multicentre clinical trial. Aliment Pharmacol Ther 8(1):119–122, 1994

    Google Scholar 

  66. Bader JP, Delchier JC: Clinical efficacy of pantoprazole compared with ranitidine. Aliment Pharmacol Ther 8(suppl 1):47–52, 1994

    Google Scholar 

  67. Schepp W, Rehner M, Witzel L: A review of treatment of duodenal and gastric ulcers—pantoprazole vs omeprazole. Aliment Pharmacol Ther 8(suppl 1):53–57, 1994

    Google Scholar 

  68. Howden CW, Hunt RH: The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther 4(1):25–33, 1990

    Google Scholar 

  69. Marshall BJ:Helicobacter pylori. Am J Gastroenterol 89(8):S116-S128, 1994

    Google Scholar 

  70. Labenz J, Ruhl GH, Bertrams J, Borsch G: Medium-or high-dose omeprazole plus amoxicillin eradicatesHelicobacter pylori in gastric ulcer disease. Am J Gastroenterol 89(5):726–730, 1994

    Google Scholar 

  71. Labenz J, Borsch G: Role ofHelicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 55(1):19–23, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The statistical analysis and computing with plot program was performed by G. Leandro, MD, Biostatistician. This work was performed under the auspices of the “Roberto Farini Foundation for Gastroenterological Research.”

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mario, F.D., Battaglia, G., Leandro, G. et al. Short-term treatment of gastric ulcer. Digest Dis Sci 41, 1108–1131 (1996). https://doi.org/10.1007/BF02088227

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02088227

Key words

Navigation